Veracyte, Inc. (VCYT) is a publicly traded Healthcare sector company. As of May 21, 2026, VCYT trades at $45.00 with a market cap of $3.31B and a P/E ratio of 40.34. VCYT moved +8.37% today. Year to date, VCYT is +3.58%; over the trailing twelve months it is +56.86%. Its 52-week range spans $22.61 to $50.71. Analyst consensus is buy with an average price target of $45.28. Rallies surfaces VCYT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading VCYT stock inside the company?
Recent VCYT insider activity includes McGuire Annie sold 5.10K, McGuire Annie sold 5.10K, Chambers Rebecca sold 4.40K, Chambers Rebecca sold 13.94K, and Stapley Marc sold 19.24K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
VCYT Key Metrics
Key financial metrics for VCYT
Metric
Value
Price
$45.00
Market Cap
$3.31B
P/E Ratio
40.34
EPS
$1.11
Dividend Yield
0.00%
52-Week High
$50.71
52-Week Low
$22.61
Volume
111
Avg Volume
0
Revenue (TTM)
$541.74M
Net Income
$88.01M
Gross Margin
70.92%
Recent VCYT Insider Trades
McGuire Annie sold 5.10K (~$194.13K) on May 6, 2026.
McGuire Annie sold 5.10K (~$204.08K) on May 6, 2026.
Chambers Rebecca sold 4.40K (~$156.41K) on Mar 4, 2026.
Chambers Rebecca sold 13.94K (~$506.46K) on Mar 4, 2026.
Stapley Marc sold 19.24K (~$684.23K) on Mar 4, 2026.
Recent VCYT insider activity includes McGuire Annie sold 5.10K, McGuire Annie sold 5.10K, Chambers Rebecca sold 4.40K, Chambers Rebecca sold 13.94K, and Stapley Marc sold 19.24K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VCYT?
Yes. Rallies tracks VCYT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VCYT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VCYT. It does not provide personalized investment advice.
